Chemotherapy combination with cyclophosp
β
J. M. Gracia; A. Jimenez
π
Article
π
1982
π
Springer
π
English
β 178 KB
Twenty-four evaluable patients with small cell carcinoma of the lung were treated with an escalating chemotherapy regimen including Cyclophosphamide, Adriamycin, Vincristine and VP16-213. The initial doses were CTX 800 mg/m2 i.v. day 1; ADR 50 mg/m2 i.v. day 1; VCR 1.4 mg/m2 day 1 weekly; and VP16-2